journal article·2023-02Open access

Modification of adipose mesenchymal stem cells-derived small extracellular vesicles with fibrin-targeting peptide CREKA for enhanced bone repair

Qi Wu, Xiaoling Fu, Xian Li, Jing Li, Weiju Han, Yingjun Wang

Abstract

The process of bone repair is highly regulated by a large number of bioactive factors. Thus, a "cocktail" of bioactive factors supplemented to the defect sites is desirable for bone repair. In this regard, small extracellular vesicles (sEVs) derived from mesenchymal stem cells hold great potential in tissue repair. Nevertheless, the poor homing and retention of sEVs greatly limited their possible clinical application. In the present work, DMPE-PEG-CREKA was inserted into the membrane of sEVs released from adipose-derived mesenchymal stem cells to obtain CREKA functionalized sEVs (CREKA-sEVs), which could target fibrin to accumulate and retain in bone defects. Our results showed that CREKA-sEVs, like sEVs, promoted the osteogenic differentiation of BMSCs, the angiogenic property of HUVECs, and modulated the polarization of macrophages in vitro. Furthermore, due to the improved fibrin-binding and retention capacity of CREKA-sEVs, they enhanced the bone repair substantially in the rat femoral defect model. This study provided a new strategy to improve the therapeutic efficiency of sEVs and showed that CREKA-sEVs had great application value in bone tissue repair.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Bone and Joint Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Scaffold design for bone regeneration10.1166/jnn.2014.9127 ↗
2. Regenerating bone with bioactive glass scaffolds: a review of in vivo studies in bone defect models10.1016/j.actbio.2017.08.030 ↗
3. Fabrication of hybrid scaffold based on hydroxyapatite-biodegradable nanofibers incorporated with liposomal formulation of BMP-2 peptide for bone tissue engineering10.1016/j.nano.2018.06.001 ↗
4. Synergistic effects of controlled-released BMP-2 and VEGF from nHAC/PLGAs scaffold on osteogenesis
5. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines10.1080/20013078.2018.1535750 ↗
6. Small extracellular vesicle loading systems in cancer therapy: current status and the way forward10.1016/j.jcyt.2019.10.002 ↗
7. Exosome theranostics: biology and translational medicine10.7150/thno.21945 ↗
8. Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways10.1186/s13287-019-1152-x ↗
9. Optimized BMSC-derived osteoinductive exosomes immobilized in hierarchical scaffold via lyophilization for bone repair through Bmpr2/Acvr2b competitive receptor-activated Smad pathway10.1016/j.biomaterials.2021.120718 ↗
10. Cardio-renal exosomes in myocardial infarction serum regulate proangiogenic paracrine signaling in adipose mesenchymal stem cells10.7150/thno.37678 ↗
11. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases10.1038/emm.2017.63 ↗
12. Mesenchymal stem cell exosomes in bone regenerative strategies - a systematic review of preclinical studies
13. Wang · Basic Clin. Pharmacol. Toxicol. · 2021 · 128 · 1810.1111/bcpt.13478 ↗
14. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles10.1002/pmic.201200373 ↗
15. Concise review: msc-derived exosomes for cell-free therapy10.1002/stem.2575 ↗
16. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy10.1161/CIRCRESAHA.110.239848 ↗
17. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting10.3402/jev.v4.26316 ↗
18. Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment10.1021/acs.nanolett.8b01816 ↗
19. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations10.1016/j.nano.2017.09.011 ↗
20. The multifaceted role of fibrinogen in tissue injury10.1182/blood-2018-07-818211 ↗
21. The evolution of fibrin-specific targeting strategies10.1039/C4TB01769B ↗
22. Biomimetic amplification of nanoparticle homing to tumors10.1073/pnas.0610298104 ↗
23. Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: strategies and significance10.1016/j.jconrel.2020.07.042 ↗
24. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy10.1016/j.biomaterials.2017.10.012 ↗
25. Targeted repair of vascular injury by adipose-derived stem cells modified with P-Selectin binding peptide10.1002/advs.201903516 ↗
26. Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics delivery vehicles for glioblastoma therapy10.1002/advs.201801899 ↗
27. Isolation and characterization of exosomes from cell culture supernatants and biological fluids
28. Long-term stable fibrin gels for cartilage engineering10.1016/j.biomaterials.2006.08.027 ↗
29. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration10.7150/thno.29766 ↗
30. 3D printing strategies for peripheral nerve regeneration10.1088/1758-5090/aaaf50 ↗
31. Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair10.1016/j.addr.2015.03.013 ↗
32. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway10.1186/s13287-016-0391-3 ↗
33. Exosomal miR-130a-3p regulates osteogenic differentiation of Human Adipose-Derived stem cells through mediating SIRT7/Wnt/β-catenin axis10.1111/cpr.12890 ↗
34. Improved small extracellular vesicle secretion of rat adipose-derived stem cells by microgrooved substrates through upregulation of the ESCRT-III-associated protein Alix
35. Efficient angiogenesis-based diabetic wound healing/skin reconstruction through bioactive antibacterial adhesive ultraviolet shielding nanodressing with exosome release10.1021/acsnano.9b03656 ↗
36. Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF‐1α‐mediated promotion of angiogenesis in a rat model of stabilized fracture10.1111/cpr.12570 ↗
37. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery10.1186/s13046-019-1027-0 ↗
38. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue10.2337/db17-0356 ↗
39. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1beta-primed mesenchymal stem cells against sepsis10.1002/stem.2564 ↗
40. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
41. Monocytes and macrophages in tissue repair: implications for immunoregenerative biomaterial design10.1177/1535370216650293 ↗
42. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential10.1186/1478-811X-12-26 ↗
43. Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis10.1186/s13287-018-1115-7 ↗